Hepatitis G virus coinfection in chronic hepatitis B and C patients in Poland. 1998

M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
Institute of Infectious Diseases, Warsaw, Poland.

This study evaluated the epidemiology and impact of hepatitis G virus (HGV) infection in patients with chronic hepatitis B and C. Serum samples were obtained from 128 consecutive untreated patients with chronic hepatitis B (72 cases) or C (56 cases). The presence of HGV RNA was determined by PCR amplification of the 5'untranslated region; the sensitivity of the assays was ten template copy equivalents. The prevalence of HGV RNA in hepatitis B and C was found to be 25% and 34%, respectively. HGV-positive and HGV-negative patients did not differ with respect to risk factors for infection, age, sex, or alanine aminotransferase activity. Similarly, there was no difference in the severity of liver disease, as assessed with HAI score. In conclusion, we found a very high prevalence of HGV infection in chronic hepatitis B and C patients in Poland. Nevertheless, no evidence was found that HGV coinfection has any impact on the severity of the underlying disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011044 Poland A country in central Europe, east of Germany. The capital is Warsaw. Polish People's Republic,Republic of Poland
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
January 1997, Scandinavian journal of infectious diseases,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
March 1997, Nihon rinsho. Japanese journal of clinical medicine,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
August 1994, Journal of hepatology,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
January 2007, Scandinavian journal of infectious diseases,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
October 2000, Liver,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
October 1997, The Journal of pediatrics,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
January 1998, Antiviral therapy,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
April 2019, Journal of medical virology,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
July 2001, Indian journal of pathology & microbiology,
M Radkowski, and W Stańczak, and B Walewska-Zielecka, and T Loch, and J Cianciara, and L F Wang, and T Laskus
August 2023, Antiviral therapy,
Copied contents to your clipboard!